comparemela.com

Latest Breaking News On - Farhad ravandi kashani - Page 1 : comparemela.com

Dr Ravandi-Kashani on the FDA Approval of Luspatercept in MDS

Risk Classification, Mutational Analysis Are Key in Informing AML Management

During an OncLive® workshop titled Key Updates in the Management of Acute Myeloid Leukemia and Their Application in Clinical Practice, moderated by Naval Daver, MD, faculty reviewed updates to the classification of acute myeloid leukemia and its effects on the treatment paradigm and provided insight on the management of adverse-risk and secondary acute myeloid leukemia.

Mexico
Washington
United-states
Ohio-state-university
Ohio
Houston
Texas
Columbus
Tampa
Florida
Georgetown-university
District-of-columbia

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.